Biotech · Private company
NorthSea Therapeutics B.V.
Track this companyFree. Adds NorthSea Therapeutics B.V. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- IcosabutatePhase 2 · Non Alcoholic Steatohepatitis (NASH)ClinicalTrials.gov · fetched Nov 12, 2026
- NST-1024Phase 2 · High TriglyceridesClinicalTrials.gov · fetched Nov 12, 2026
- NST-6179 Part APhase 2 · Intestinal Failure Associated Liver DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- NST-6179 Part BPhase 2 · Intestinal Failure Associated Liver DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).PHASE2 · RECRUITING · started Jan 15, 2024ClinicalTrials.gov NCT05919680 · fetched Nov 12, 2026
- Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With HypertriglyceridemiaPHASE2 · COMPLETED · started Jun 30, 2023ClinicalTrials.gov NCT05889156 · fetched Nov 12, 2026
- A Phase 2b Study of Icosabutate in Fatty Liver DiseasePHASE2 · COMPLETED · started Jul 17, 2019ClinicalTrials.gov NCT04052516 · fetched Nov 12, 2026